3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.

Caruso, Michele

3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience. [electronic resource] - Future oncology (London, England) 2015 - 3109-12 p. digital

Publication Type: Letter

1744-8301

10.2217/fon.15.261 doi


Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Gonadotropin-Releasing Hormone--agonists
Humans
Neoplasm Staging
Premenopause
Receptors, Estrogen--metabolism
Receptors, Progesterone
Treatment Outcome
Triptorelin Pamoate--therapeutic use